Kestra Medical Technologies, Ltd.
KMTS Nasdaq
SEC CIK 1877184
Follow Kestra Medical Technologies, Ltd.
Weekly email: filings, results
Revenue, last quarter
$31M
+59.9% vs same quarter last year
Net income
−$44.1M
−70.7% vs same quarter last year
EPS, diluted
−$0.75
−50% vs same quarter last year
Operating cash flow
−$32.3M
−22.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $95.1M | −$131.6M |
| FY25 | $59.8M | −$113.8M |
| FY24 | $27.8M | −$94.1M |
| FY23 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 51.4% | −141.6% | −138.4% |
| FY25 | 40.5% | −177.8% | −190.3% |
| FY24 | 1.3% | −305.8% | −338.4% |
| FY23 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$116.6M |
| FY25 | −$100.5M |
| FY24 | −$84.5M |
| FY23 | - |
- Kestra Medical Technologies, Ltd.
- Healthcare median
Show the numbers
| Year | Kestra Medical Technologies, Ltd. | Healthcare median |
|---|---|---|
| FY26 | −138.4% | −11.1% |
| FY25 | −190.3% | −30.6% |
| FY24 | −338.4% | −47% |
| FY23 | - | −58% |